Our previous study demonstrated that ZNF32 could protect breast cancer cells from stimulus-induced cell death.34 ZNF32 overexpression has been shown to markedly increase the ability of cells to protect against oxidative stress-induced injury.35 These findings suggest that ZNF32 might enable the tolerance of cancer to anti-tumor drugs. This evidence concerns the gene ZNF32 and neoplasm.